Internal Medicine, Nephrology · San Bernardino, CA
NPI
1902040819
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
401 E Highland Ave, Suite 551
San Bernardino, CA, 92404
Phone (909) 882-9150
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
1,634 services
Medicare patients, 2024
335
Average age 70
Drug cost, 2024
$951K
2,555 prescriptions
Company payments, 2025
$104
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James P Tomas was code 99232 (hospital e&m - subsequent), 704 times for 215 patients. In total James P Tomas billed 1,634 services in 30 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 704 | 215 | $61.92 | $44K |
| 90960 ESRD Related Services (not dialysis) | Office | 176 | 27 | $274.61 | $48K |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 47 | $94.40 | $11K |
| 99214 Office E&M - Established | Office | 78 | 38 | $72.15 | $5,627 |
| 99222 Hospital E&M - Initial | Facility | 69 | 67 | $101.80 | $7,024 |
| 90935 Hemodialysis | Facility | 43 | 35 | $56.29 | $2,421 |
| 99223 Hospital E&M - Initial | Facility | 42 | 40 | $134.06 | $5,630 |
| 99213 Office E&M - Established | Office | 35 | 24 | $54.37 | $1,903 |
| 90961 ESRD Related Services (not dialysis) | Office | 30 | 13 | $235.06 | $7,052 |
| 81003 Clinical Chemistry | Office | 19 | 13 | $2.20 | $41.8 |
| 85025 Blood Count | Office | 18 | 13 | $7.61 | $137 |
| 84550 Clinical Chemistry | Office | 16 | 13 | $4.43 | $70.88 |
| 82570 Clinical Chemistry | Office | 15 | 12 | $5.08 | $76.2 |
| 82043 Clinical Chemistry | Office | 14 | 11 | $5.66 | $79.24 |
By year: 2022 $193K for 2,065 services; 2023 $155K for 1,726 services; 2024 $141K for 1,634 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 19 | 13 | $2.20 | $41.8 |
| 85025 Blood Count | 18 | 13 | $7.61 | $137 |
| 84550 Clinical Chemistry | 16 | 13 | $4.43 | $70.88 |
| 82570 Clinical Chemistry | 15 | 12 | $5.08 | $76.2 |
| 82043 Clinical Chemistry | 14 | 11 | $5.66 | $79.24 |
Medicare prescription drug claims, 2024
In 2024, the drug James P Tomas prescribed most often to Medicare patients was Allopurinol, with 322 prescriptions and refills. In total James P Tomas wrote 2,555 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 322 | 720 | 80 | $2,826 |
| Rayaldee Calcifediol | 252 | 258 | 29 | $307K |
| Lokelma Sodium Zirconium Cyclosilicate | 138 | 147 | 29 | $113K |
| Auryxia Ferric Citrate | 135 | 143 | 22 | $94K |
| Losartan Potassium Generic | 134 | 328 | 42 | $1,158 |
| Veltassa Patiromer Calcium Sorbitex | 131 | 133 | 31 | $124K |
| Hydralazine Hcl Generic | 123 | 232 | 30 | $1,670 |
| Prosol Parenteral Amino Acid 20% No.1 | 88 | 88 | Under 11 | $15K |
| Atenolol Generic | 83 | 187 | 24 | $582 |
| Furosemide Generic | 78 | 189 | 27 | $741 |
| Amlodipine Besylate Generic | 77 | 192 | 23 | $575 |
| Calcitriol Generic | 74 | 150 | 21 | $1,636 |
| Dapagliflozin Dapagliflozin Propanediol | 74 | 76 | 16 | $37K |
| Lisinopril Generic | 64 | 118 | 15 | $229 |
| Carvedilol Generic | 58 | 120 | 15 | $479 |
Brand drugs: - claims; generic drugs: 1,527 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James P Tomas $104 ($104 in general payments such as food, travel and fees) from 5 companies. The largest payer was Apellis Pharmaceuticals, Inc. with $35.82.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.